Ｐａｇｅ 120511 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 通常モードに戻る ┃ ＩＮＤＥＸ ┃ ≪前へ │ 次へ≫ ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ▼EMEA Recommends a N fuesitiouri 08/7/4(金) 5:59 ─────────────────────────────────────── ■題名 ： EMEA Recommends a N ■名前 ： fuesitiouri <jateexesced@jetfix.ee> ■日付 ： 08/7/4(金) 5:59 ■Ｗｅｂ ： http://google.com/zwtxkz -------------------------------------------------------------------------
| LONDON, June 1, 2008-The uropean Medicjnes power (EMEA) has recommended updating the result dirt for epoetin-containing medicines with a new caution for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia in patients torture cancer. Epoetin-containing medicines are indicated in patients with great-lasting acheter viagrras incompetent and for the treatment of anaemia in symptomatic patients with non-myeloid growths receiving chemotherapy. The power痴 cabinet for remedial Products for Good Samaritan Use (CHMP) had rehashinged new facts from studies that showed an increased hazard of sarocma acheter levitra generique movement forward, venous thromboembolism and shorter all- inclusive survival in cancer patients who cleard epoetins compared to patients who did not clear them. Following this rehashing, tne CHMP concluded, at its June 2008 conference, that the improves of epoetins persist acheter cialis generique surpass their hazards in the approved indications. after all, in cancer patients with a reasonably lengthy enthusiasm-expectancy, the emoluments of using epoetins does not surpass the enadnger achat cialis growth ascension and shorter inclusive survival and consequently the council concluded that in these patients anaemia should be corrected with blood transfusions. |